Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters

NCT03679286 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-04-16

No results posted yet for this study

Summary

To determine if PMC viscoelastic coagulation parameters correlate with those generated by a marketed device in adult patients who require hemostasis monitoring or who are at risk of bleeding or thrombotic indications

Conditions

  • Hemostasis Monitoring

Interventions

DEVICE

PCM and ROTEM

Test of blood sample by both PCM and ROTEM

Sponsors & Collaborators

  • Entegrion, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-20
Primary Completion
2020-12-31
Completion
2021-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03679286 on ClinicalTrials.gov